214
Participants
Start Date
February 28, 2007
Primary Completion Date
August 31, 2009
Study Completion Date
August 31, 2009
ASCs (Cx401, company code)
"Experimental: ASCs: Subjects will be treated with a dose of 20 million ASCs and evaluated after 12 weeks. If needed a second dose of 40 million ASCs will be applied then.~Experimental: ASCs+fibrin glue: Subjects will be treated with a dose of 20 million ASCs plus fibrin glue and evaluated after 12 weeks. If needed a second dose of 40 million ASCs plus fibrin glue will be applied then."
Fibrin adhesive
Experimental: Fibrin glue: Subjects will be treated with a dose fibrin glue and evaluated after 12 weeks. If needed a second dose of fibrin glue will be applied then.
Gregorio Marañon University Hospital, Madrid
San Carlos Clinical Hospital, Madrid
12 De Octubre University Hospital, Madrid
La Paz University Hospital, Madrid
Virgen Del Camino Hospital, Pamplona
Universitary General Hospital, Valencia
Lozano Blesa Clinical Hospital, Zaragoza
Universitary Clinical Surgery, Mannheim
Mutua de Terrasa Hospital, Tarrasa
John Radcliff Hospital, Oxford
Tigenix S.A.U.
INDUSTRY